Trials / Terminated
TerminatedNCT00985478
First in Man Study With SLV342
A Double-blind, Randomized, Placebo-controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SLV342 in Young Healthy Male Subjects
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Abbott Products · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
First in man study with single and multiple rising doses with SLV342
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SLV342 | 25 mg once daily - Maximal Tolerated Dose |
| DRUG | placebo | matching placebo |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2010-06-01
- Completion
- 2010-06-01
- First posted
- 2009-09-28
- Last updated
- 2011-08-25
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00985478. Inclusion in this directory is not an endorsement.